Inflammatory myopathies

Clinical characteristics of patients with antisynthetase syndrome and dermatomyositis-type skin involvement: Insights from the Myo-Spain registry

Semin Arthritis RheumPublished Cross-sectional study

Authors' conclusion

ASyS-DM-skin patients displayed a distinct clinical phenotype, characterized by DM-type cutaneous involvement while retaining ASyS features, particularly interstitial lung disease, Raynaud's phenomenon, and mechanic's hands.

Study context

Population
Baseline data from the Spanish registry of patients with IIM (Myo-Spain): patients with anti-synthetase syndrome (ASyS) and dermatomyositis (DM)194 ASyS, 116 DM
Exposure
ASyS with DM-type skin lesions vs ASyS without DM-type skin lesions and vs DM
  • ASyS-DM-skinn = 61
  • DMn = 116
Outcome
Factors associated with DM-type skin lesions among ASyS patients (multivariable)
Methodological detailsregistry-based (Myo-Spain), multivariable logistic regression
  • Registry-based (Myo-Spain)
  • Multivariable logistic regression

Main finding

As reported in the abstract

Periungual capillary alterations: OR

2.49

95% CI 1.10–5.65

Age at diagnosis: OR

0.97

95% CI 0.94–0.99

Arthralgia: OR

0.39

95% CI 0.15–1.00

Observational data: associations, not effects.

Further findings

Factors associated with ASyS diagnosis among patients with DM-type skin lesions (multivariable)

Raynaud's phenomenon: OR
6.84 (95% CI 1.04-44.81)
Mechanic's hands: OR
12.60 (95% CI 1.55-102.7)
ILD: OR
27.83 (95% CI 4.55-170.5)
Heliotrope rash or Gottron sign/papules: OR
0.10 (95% CI 0.01-0.73)
Muscle weakness at diagnosis: OR
0.11 (95% CI 0.01-0.83)

Malignancy

Less frequent in ASyS-DM-skin than in DM

Original publication

Clinical characteristics of patients with antisynthetase syndrome and dermatomyositis-type skin involvement: Insights from the Myo-Spain registry. Semin Arthritis Rheum. Published 29 July 2026. doi:10.1016/j.semarthrit.2026.153048

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.